Previous Close | 251.82 |
Open | 251.57 |
Bid | 251.69 x 900 |
Ask | 251.81 x 800 |
Day's Range | 250.69 - 252.97 |
52 Week Range | 215.90 - 277.29 |
Volume | |
Avg. Volume | 1,432,488 |
Market Cap | 71.607B |
Beta (5Y Monthly) | 0.63 |
PE Ratio (TTM) | 47.80 |
EPS (TTM) | 5.26 |
Earnings Date | Feb 01, 2023 - Feb 06, 2023 |
Forward Dividend & Yield | 3.48 (1.51%) |
Ex-Dividend Date | Sept 08, 2022 |
1y Target Est | 277.82 |
Cardinal Health's (CAH) second-quarter fiscal 2023 results are likely to reflect solid performance in the Pharmaceutical segment. However, inflation and supply chain constraints are likely to have continued.
McKesson's (MCK) fiscal third-quarter results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.
Becton Dickinson (BDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.